SCHEMBL4100931

SCHEMBL4100931

CCC(C)[CH]C(N)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2582192 1.00
SCHEMBL3512841 0.76
SCHEMBL2584566 0.76
SCHEMBL5052046 0.75 ECE1 (0.31)
SCHEMBL2140279 0.75 ECE1 (0.31)
SCHEMBL27531567 0.73
SCHEMBL8837390 0.69 KDM4E (0.32)
SCHEMBL8211133 0.69 KDM4E (0.32)
Thiourea SCHEMBL9443171 0.67 TSHR (0.40)
SCHEMBL27705562 0.67 TSHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273716-B2 Use of LHRH antagonists for intermittent treatments SPECTRUM PHARMACEUTICALS, INC. (US) 2012-09-25 US disclosed
US-20090221569-A1 USE OF LHRH ANTAGONISTS FOR INTERMITTENT TREATMENTS AETERNA ZENTARIS GMBH (DE) 2009-09-03 US disclosed
US-7375127-B2 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) AE ZENTARIS GMBH (DE) 2008-05-20 US disclosed
US-20060014818-A1 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2006-01-19 US disclosed